InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Payne Joseph E, Director. Officer active across 2 companies, notably Vallon Pharmaceuticals, Inc.. Aggregated, 3 disclosures have been recorded. Split: 3 buys · 0 sell. Total volume traded: €147k. Activity tracked since 25 May 2021. The latest transaction was disclosed on 23 November 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
5,000 shares@ US$16.51100.0% of flowCommon StockSEC:0001193805-22-001614:0
Ideal exit: 20 Aug 2023 (T+270)
10,700 shares@ US$3.8550.0% of flowCommon StockSEC:0001104659-21-073495:0
Ideal exit: 19 Feb 2022 (T+270)
10,700 shares@ US$3.8550.0% of flowCommon StockSEC:0001104659-21-073495
Ideal exit: 19 Feb 2022 (T+270)
3 of 3 declarations
About Payne Joseph E
Joseph E. Payne is a Board Member at Vallon Pharmaceuticals, Inc. He contributes to the strategic direction of the company, which focuses on developing innovative treatments for substance use disorders. With significant experience in the pharmaceutical sector, he plays a key role in strategic decisions and governance of the company.
